Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.2360
+0.1610
+(14.98%)
At close: February 21 at 5:32:30 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 10VA.F | -- | -- | -- | -- |
| S&P 500 | 14.59% | 7.61% | 10.87% | 14.11% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/21/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/20/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/7/2025 |
| Initiated | HC Wainwright & Co.: Buy | 11/25/2024 |
| Maintains | EF Hutton: Buy to Buy | 11/7/2024 |
| Maintains | EF Hutton: Buy to Buy | 10/22/2024 |
Related Tickers
96X.F FluoGuide A/S
3.7550
-6.24%
NV4.F Cellectar Biosciences, Inc.
0.2600
-23.53%
RGO.DU Regeneron Pharmaceuticals Inc
657.40
+1.20%
600161.SS TIANTAN BIO
20.05
-0.35%
PH4.F CStone Pharmaceuticals
0.3720
+4.49%
HQ1.MU Oruka Therapeutics Inc. R
10.60
+0.95%
GYX.F Futura Medical plc
0.1770
+14.94%
BSSP Baseline Productions, Inc.
0.0001
0.00%
22UA.DU BioNTech SE
114.70
+2.59%
2563.HK Beijing Biostar Pharms Co Ltd
17.680
-1.78%